[Creation of synthetic serine proteinase inhibitors, an important pharmacological problem].
D000215:Acylation; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D003169:Complement Inactivator Proteins / Q000494:pharmacology; D004789:Enzyme Activation; D006801:Humans; D007705:Kinins / Q000037:antagonists & inhibitors; D046911:Macromolecular Substances; D010447:Peptide Hydrolases / Q000097:blood; D011480:Protease Inhibitors / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D012694:Serine / Q000097:blood; D013379:Substrate Specificity / Q000187:drug effects
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003169:Complement Inactivator Proteins; D007705:Kinins; D046911:Macromolecular Substances; D011480:Protease Inhibitors; D012694:Serine; D010447:Peptide Hydrolases
Sozdanie sinteticheskikh ingibitorov serinproteinaz--vazhnaia problema farmakologii.